Epizyme has taken another step forward on the path to its first commercialized drug, announcing Thursday submission of an application to the Food and Drug Administration for accelerated approval of its most advanced experimental cancer drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,